0001140361-11-026751.txt : 20110511 0001140361-11-026751.hdr.sgml : 20110511 20110511182504 ACCESSION NUMBER: 0001140361-11-026751 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20110509 FILED AS OF DATE: 20110511 DATE AS OF CHANGE: 20110511 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Lievense Jefferson CENTRAL INDEX KEY: 0001501909 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-34885 FILM NUMBER: 11833256 MAIL ADDRESS: STREET 1: C/O AMYRIS, INC. STREET 2: 5885 HOLLIS ST., SUITE 100 CITY: EMERYVILLE STATE: CA ZIP: 94608 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: AMYRIS, INC. CENTRAL INDEX KEY: 0001365916 STANDARD INDUSTRIAL CLASSIFICATION: INDUSTRIAL ORGANIC CHEMICALS [2860] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 5885 HOLLIS ST SUITE 100 CITY: EMERYVILLE STATE: CA ZIP: 94608 BUSINESS PHONE: 510-450-0761 MAIL ADDRESS: STREET 1: 5885 HOLLIS ST SUITE 100 CITY: EMERYVILLE STATE: CA ZIP: 94608 FORMER COMPANY: FORMER CONFORMED NAME: AMYRIS BIOTECHNOLOGIES INC DATE OF NAME CHANGE: 20060613 4 1 doc1.xml FORM 4 X0303 4 2011-05-09 0 0001365916 AMYRIS, INC. AMRS 0001501909 Lievense Jefferson C/O AMYRIS, INC. 5885 HOLLIS ST., SUITE 100 EMERYVILLE CA 94608 0 1 0 0 SVP, Process Dev. & Mfg. Common Stock 2011-05-09 4 M 0 24000 3.93 A 34000 I By the Lievense Revocable Trust Common Stock 2011-05-09 4 S 0 23900 24.8803 D 10100 I By the Lievense Revocable Trust Common Stock 2011-05-09 4 S 0 100 25.40 D 10000 I By the Lievense Revocable Trust Stock Option (Right to Buy) 3.93 2011-05-09 4 M 0 24000 0 D 2017-12-12 Common Stock 24000 150000 I By the Lievense Revocable Trust. The transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 15, 2010. Represents the aggregate of sales effected on the same day at different prices pursuant to the plan in footnote (1). Represents the weighted average sales price per share. The shares sold at prices ranging from $24.26 to $25.24 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer. Immediately exercisable. The stock option vested as to 1/5th of the total number of shares subject to the option on December 3, 2008, and thereafter vested and shall vest as to 1/60th of the total number of shares subject to the option in equal monthly installments. The Reporting Person transferred this option to the Lievense Revocable Trust on February 16, 2011. The Reporting Person is a Trustee of the Lievense Revocable Trust. Exhibit List Exhibit 24 - Power of Attorney /s/ Jefferson Lievense by Tamara Tompkins, Attorney-in-Fact 2011-05-11 EX-24 2 poa1.htm POWER OF ATTORNEY Exhibit 24

POWER OF ATTORNEY

KNOW ALL BY THESE PRESENTS, that the undersigned hereby constitutes and appoints Jeryl Hilleman, Tamara Tompkins, Nicholas Khadder, Andrew Ancheta and Jeannine Hensley, each with power to act without the other, his or her true and lawful attorney-in-fact to:

(1) execute for and on behalf of the undersigned, in the undersigned's capacity as a representative of Amyris, Inc. (the "Company"), any and all Form ID filings, Forms 3, 4 and 5 reports required to be filed by the undersigned in accordance with Section 16(a) of the Securities Act of 1934 and the rules and regulations thereunder with respect to transactions in Company securities;

(2) do and perform any and all acts for and on behalf of the undersigned which may be necessary or desirable to complete and execute any such Form ID filings, Forms 3, 4 and 5 and timely file such forms with the United States Securities and Exchange Commission and any stock exchange or similar authority; and

(3) take any other action which, in the opinion of such attorney-in-fact, may be of benefit to, in the best interest of, or legally required by, the undersigned in connection with the foregoing powers.

The undersigned hereby grants to such attorney-in-fact full power and authority to do and perform any and every act and thing whatsoever requisite, or proper to be done in the exercise of any of the rights and powers herein granted, as fully to all intents and purposes as the undersigned might or could do if personally present, with full power of substitution or revocation, hereby ratifying and confirming all that any such attorney-in-fact, or such attorney-in-fact's substitute or substitutes, shall lawfully do or cause to be done by virtue of this power of attorney and the rights and powers herein granted. The undersigned acknowledges that each such attorney-in-fact, in serving in such capacity at the request of the undersigned, is not assuming, nor is the Company assuming, any of the undersigned's responsibilities to comply with Section 16 of the Securities Act of 1934.

This Power of Attorney shall remain in full force and effect until the undersigned is no longer required to file Forms 3, 4 or 5 with respect to the undersigned's holdings of and transactions in Company securities, unless earlier revoked by the undersigned in a signed writing delivered to any of the foregoing attorneys-in-fact.

IN WITNESS WHEREOF, the undersigned has caused this Power of Attorney to be executed as of this 10th day of May, 2011.

By: /s/ Jefferson C. Lievense
(signature)

Name: Jefferson C. Lievense
(print name)